Den europeiske union -
norsk -
EMA (European Medicines Agency)
orfadin
swedish orphan biovitrum international ab - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).
Norge -
norsk -
Statens legemiddelverk
imigran radis 100 mg
glaxosmithkline as - sumatriptansuksinat - tablett, filmdrasjert - 100 mg
Norge -
norsk -
Statens legemiddelverk
imigran radis 50 mg
glaxosmithkline as - sumatriptansuksinat - tablett, filmdrasjert - 50 mg
Norge -
norsk -
Statens legemiddelverk
imigran 100 mg
glaxosmithkline as - sumatriptansuksinat - tablett, filmdrasjert - 100 mg
Norge -
norsk -
Statens legemiddelverk
imigran 12 mg/ ml
glaxosmithkline as - sumatriptansuksinat - injeksjonsvæske, oppløsning - 12 mg/ ml
Norge -
norsk -
Statens legemiddelverk
imigran 20 mg/ dose
glaxosmithkline as - sumatriptansuksinat - nesespray, oppløsning - 20 mg/ dose
Norge -
norsk -
Statens legemiddelverk
imigran 50 mg
glaxosmithkline as - sumatriptansuksinat - tablett, filmdrasjert - 50 mg
Norge -
norsk -
Statens legemiddelverk
imigran 20 mg/ dose
farmagon - sumatriptansuksinat - nesespray, oppløsning - 20 mg/ dose